In vivo physiological and transcriptional profiling reveals host responses to clostridium difficile toxin A and toxin B

Infection and Immunity

Volumn 81, Issue 10, 2013, Pages 3814-3824

  D'Auria, Kevin M ^a   Kolling, Glynis L ^b   Donato, Gina M ^b   Warren, Cirle A ^b   Gray, Mary C ^b   Hewlett, Erik L ^b   Papin, Jason A ^a  

^a University of Virginia   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; BLOOD CELL COUNT; CONTROLLED STUDY; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; IN VIVO STUDY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEPTOR UPREGULATION; TRANSIENT EXPRESSION;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CECUM; ENTEROTOXINS; GENE EXPRESSION REGULATION; MICE; MICE, INBRED C57BL; TRANSCRIPTOME;

EID: 84884358530     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00869-13     Document Type: Article

References (52)

1. Lucado J, Gould C, Elixhauser A. 2012. Clostridium difficile infections (CDI) in hospital stays, 2009. HCUP statistical brief 124. Agency for Healthcare Research and Quality, Rockville, MD.
2. Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW. 2010. Economic healthcare costs of Clostridium difficile infection: a systematic review. J. Hosp. Infect. 74:309-318.
3. McGlone SM, Bailey RR, Zimmer SM, Popovich MJ, Tian Y, Ufberg P, Muder RR, Lee BY. 2012. The economic burden of Clostridium difficile. Clin. Microbiol. Infect. 18:282-289.
4. Dubberke ER, Olsen MA. 2012. Burden of Clostridium difficile on the healthcare system. Clin. Infect. Dis. 55(Suppl. 2):S88-S92.
5. Lyras D, O'Connor JR, Howarth PM, Sambol SP, Carter GP, Phumoonna T, Poon R, Adams V, Vedantam G, Johnson S, Gerding DN, Rood JI. 2009. Toxin B is essential for virulence of Clostridium difficile. Nature 458:1176-1179.
6. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, Minton NP. 2010. The role of toxin A and toxin B in Clostridium difficile infection. Nature 467:711-713.
7. Libby JM, Jortner BS, Wilkins TD. 1982. Effects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters. Infect. Immun. 36:822-829.
8. Von Eichel-Streiber C, Laufenberg-Feldmann R, Sartingen S, Schulze J, Sauerborn M. 1992. Comparative sequence analysis of the Clostridium difficile toxins A and B. Mol. Gen. Genet. 233:260-268.
9. Chaves-Olarte E, Weidmann M, Eichel-Streiber C, Thelestam M. 1997. Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells. J. Clin. Investig. 100:1734-1741.
10. Taylor NS, Thorne GM, Bartlett JG. 1981. Comparison of two toxins produced by Clostridium difficile. Infect. Immun. 34:1036-1043.
11. Jank T, Aktories K. 2008. Structure and mode of action of clostridial glucosylating toxins: the ABCD model. Trends Microbiol. 16:222-229.
12. Carter GP, Rood JI, Lyras D. 2012. The role of toxin A and toxin B in the virulence of Clostridium difficile. Trends Microbiol. 20:21-29.
13. Drudy D, Fanning S, Kyne L. 2007. Toxin A-negative, toxin B-positive Clostridium difficile. Int. J. Infect. Dis. 11:5-10.
14. Small JD. 1968. Fatal enterocolitis in hamsters given lincomycin hydrochloride. Lab. Anim. Care 18:411-420.
15. Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. 1977. Clindamycin- associated colitis due to a toxin-producing species of Clostridium in hamsters. J. Infect. Dis. 136:701-705.
16. Lyerly DM, Saum KE, MacDonald DK, Wilkins TD. 1985. Effects of Clostridium difficile toxins given intragastrically to animals. Infect. Immun. 47:349-352.
17. Savidge TC, Pan WH, Newman P, O'Brien M, Anton PM, Pothoulakis C. 2003. Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine. Gastroenterology 125:413-420.
18. Rolfe RD. 1991. Binding kinetics of Clostridium difficile toxins A and B to intestinal brush border membranes from infant and adult hamsters. Infect. Immun. 59:1223-1230.
19. Krivan HC, Clark GF, Smith DF, Wilkins TD. 1986. Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc. Infect. Immun. 53:573-581.
20. Tucker KD, Wilkins TD. 1991. Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and Y. Infect. Immun. 59:73-78.
21. Rolfe RD, Song W. 1995. Immunoglobulin and non-immunoglobulin components of human milk inhibit Clostridium difficile toxin A-receptor binding. J. Med. Microbiol. 42:10-19.
22. Pothoulakis C, Gilbert RJ, Cladaras C, Castagliuolo I, Semenza G, Hitti Y, Montcrief JS, Linevsky J, Kelly CP, Nikulasson S, Desai HP, Wilkins TD, LaMont JT. 1996. Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin A. J. Clin. Investig. 98:641-649.
23. Pothoulakis C, Galili U, Castagliuolo I, Kelly CP, Nikulasson S, Dudeja PK, Brasitus TA, LaMont JT. 1996. A human antibody binds to alphagalactose receptors and mimics the effects of Clostridium difficile toxin A in rat colon. Gastroenterology 110:1704-1712.
24. Na X, Kim H, Moyer MP, Pothoulakis C, LaMont JT. 2008. gp96 is a human colonocyte plasma membrane binding protein for Clostridium difficile toxin A. Infect. Immun. 76:2862-2871.
25. El-Hawiet A, Kitova EN, Kitov PI, Eugenio L, Ng KK, Mulvey GL, Dingle TC, Szpacenko A, Armstrong GD, Klassen JS. 2011. Binding of Clostridium difficile toxins to human milk oligosaccharides. Glycobiology 21:1217-1227.
26. D'Auria KM, Donato GM, Gray MC, Kolling GL, Warren CA, Cave LM, Solga MD, Lannigan JA, Papin JA, Hewlett EL. 2012. Systems analysis of the transcriptional response of human ileocecal epithelial cells to Clostridium difficile toxins and effects on cell cycle control. BMC Syst. Biol. 6:2. doi:10.1186/1752-0509-6-2.
27. Sun X, Savidge T, Feng H. 2010. The enterotoxicity of Clostridium difficile toxins. Toxins (Basel) 2:1848-1880.
28. Madan R, Petrie WA, Jr. 2012. Immune responses to Clostridium difficile infection. Trends Mol. Med. 18:658-666.
29. Steele J, Chen K, Sun X, Zhang Y, Wang H, Tzipori S, Feng H. 2012. Systemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal models. J. Infect. Dis. 205:384-391.
30. Morteau O, Castagliuolo I, Mykoniatis A, Zacks J, Wlk M, Lu B, Pothoulakis C, Gerard NP, Gerard C. 2002. Genetic deficiency in the chemokine receptor CCR1 protects against acute Clostridium difficile toxin A enteritis in mice. Gastroenterology 122:725-733.
31. Kelly CP, Becker S, Linevsky JK, Joshi MA, O'Keane JC, Dickey BF, LaMont JT, Pothoulakis C. 1994. Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit. J. Clin. Investig. 93:1257-1265.
32. Kokkotou E, Espinoza DO, Torres D, Karagiannides I, Kosteletos S, Savidge T, O'Brien M, Pothoulakis C. 2009. Melanin-concentrating hormone (MCH) modulates C difficile toxin A-mediated enteritis in mice. Gut 58:34-40.
33. Ishida Y, Maegawa T, Kondo T, Kimura A, Iwakura Y, Nakamura S, Mukaida N. 2004. Essential involvement of IFN-gamma in Clostridium difficile toxin A-induced enteritis. J. Immunol. 172:3018-3025.
34. Castagliuolo I, Keates AC, Wang CC, Pasha A, Valenick L, Kelly CP, Nikulasson ST, LaMont JT, Pothoulakis C. 1998. Clostridium difficile toxin A stimulates macrophage-inflammatory protein-2 production in rat intestinal epithelial cells. J. Immunol. 160:6039-6045.
35. Warny M, Keates AC, Keates S, Castagliuolo I, Zacks JK, Aboudola S, Qamar A, Pothoulakis C, LaMont JT, Kelly CP. 2000. p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. J. Clin. Investig. 105:1147-1156.
36. Alcantara CS, Jin XH, Brito GA, Carneiro-Filho BA, Barrett LJ, Carey RM, Guerrant RL. 2005. Angiotensin II subtype 1 receptor blockade inhibits Clostridium difficile toxin A-induced intestinal secretion in a rabbit model. J. Infect. Dis. 191:2090-2096.
37. Becker SM, Cho K-N, Guo X, Fendig K, Oosman MN, Whitehead R, Cohn SM, Houpt ER. 2010. Epithelial cell apoptosis facilitates Entamoeba histolytica infection in the gut. Am. J. Pathol. 176:1316-1322.
38. Pawlowski SW, Calabrese G, Kolling GL, Freire R, AlcantaraWarren C, Liu B, Sartor RB, Guerrant RL. 2010. Murine model of Clostridium difficile infection with aged gnotobiotic C57BL/6 mice and a BI/NAP1 strain. J. Infect. Dis. 202:1708-1712.
39. Albert EJ, Duplisea J, Dawicki W, Haidl ID, Marshall JS. 2011. Tissue eosinophilia in a mouse model of colitis is highly dependent on TLR2 and independent of mast cells. Am. J. Pathol. 178:150-160.
40. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264.
41. Baldi P, Long AD. 2001. A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics 17:509-519.
42. Wu D, Smyth GK. 2012. Camera: a competitive gene set test accounting for inter-gene correlation. Nucleic Acids Res. 40:e133.
43. Starkey ML, Davies M, Yip PK, Carter LM, Wong DJ, McMahon SB, Bradbury EJ. 2009. Expression of the regeneration-associated protein SPRR1A in primary sensory neurons and spinal cord of the adult mouse following peripheral and central injury. J. Comp. Neurol. 513:51-68.
44. LinhoffMW, Lauren J, Cassidy RM, Dobie FA, Takahashi H, Nygaard HB, Airaksinen MS, Strittmatter SM, Craig AM. 2009. An unbiased expression screen for synaptogenic proteins identifies the LRRTM protein family as synaptic organizers. Neuron 61:734-749.
45. Gerhard R, Tatge H, Genth H, Thum T, Borlak J, Fritz G, Just I. 2005. Clostridium difficile toxin A induces expression of the stress-induced early gene product RhoB. J. Biol. Chem. 280:1499-1505.
46. Hirota SA, Iablokov V, Tulk SE, Schenck LP, Becker H, Nguyen J, Al Bashir S, Dingle TC, Laing A, Liu J, Li Y, Bolstad J, Mulvey GL, Armstrong GD, MacNaughton WK, Muruve DA, MacDonald JA, Beck PL. 2012. Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure. Infect. Immun. 80:4474-4484.
47. Zeiser J, Gerhard R, Just I, Pich A. 2013. Substrate specificity of clostridial glucosylating toxins and their function on colonocytes analyzed by proteomics techniques. J. Proteome Res. [Epub ahead of print.] doi:10.1021/pr300973q.
48. Kim B-H, Shenoy AR, Kumar P, Bradfield CJ, Macmicking JD. 2012. IFN-inducible GTPases in host cell defense. Cell Host Microbe 12:432-444.
49. Nam HJ, Kang JK, Kim SK, Ahn KJ, Seok H, Park SJ, Chang JS, Pothoulakis C, Lamont JT, Kim H. 2010. Clostridium difficile toxin A decreases acetylation of tubulin, leading to microtubule depolymerization through activation of histone deacetylase 6, and this mediates acute inflammation. J. Biol. Chem. 285:32888-32896.
50. Ng J, Hirota SA, Gross O, Li Y, Ulke-Lemee A, Potentier MS, Schenck LP, Vilaysane A, Seamone ME, Feng H, Armstrong GD, Tschopp J, Macdonald JA, Muruve DA, Beck PL. 2010. Clostridium difficile toxininduced inflammation and intestinal injury are mediated by the inflammasome. Gastroenterology 139:542-552.
51. Castagliuolo I, LaMont JT, Letourneau R, Kelly C, O'Keane JC, Jaffer A, Theoharides TC, Pothoulakis C. 1994. Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum. Gastroenterology 107:657-665.
52. El Feghaly RE, Stauber JL, Deych E, Gonzalez C, Phillip I, Haslam DB, Louis S, Ave E, States U. 2013. Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection. Clin. Infect. Dis. 56:1713-1721